Close  

PAO files complaint vs Duque, Garin, 40 others for doctor’s death

/ 05:05 AM January 25, 2019

The Public Attorney’s Office (PAO) wants Health Secretary Francisco Duque III, former Health Secretary Janette Garin and other health and pharmaceutical officials to answer for the death of a physician who was inoculated with the dengue vaccine Dengvaxia by the government.

Kendrick Gotoc, 39, was the 31st alleged victim of the mass immunization program, according to the latest PAO complaint in the Department of Justice (DOJ).

ADVERTISEMENT

The PAO asked the DOJ to file an additional case against Duque, Garin and some 40 others for reckless imprudence resulting in homicide, torture, and violation of consumer rights for Gotoc’s death.

Gotoc died in April last year after getting three doses of Dengvaxia. The PAO said he had not contacted dengue before he received the vaccine.

FEATURED STORIES

Multiple organ failure

The doctor reportedly died of multiple organ failure and hemorrhage and from neurotropic-like disease and viscerotropic-like disease secondary to Dengvaxia vaccination, according to the PAO.

It said Department of Health officials, Dengvaxia manufacturer Sanofi Pasteur and the vaccine’s Philippine distributor Zuellig Pharma “deliberately failed to inform the Dengvaxia recipients and their parents/ families of the dangers and risks related to Dengvaxia and did not obtain their informed consent.” —DONA Z. PAZZIBUGAN

Read Next
LATEST STORIES
MOST READ
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: DoH, Health Secretary Francisco Duque III, Janette Garin, Kendrick Gotoc, PAO
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2019 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.